PharmiWeb.com - Global Pharma News & Resources

Clinical trials - Press Releases

Date Title Company
26-Sep-2020 Agilex Biolabs Develops World's Most Accurate Cannabinoid Assay Agilex Biolabs
25-Sep-2020 PharmiWeb.Jobs welcomes Medella Life Medella Life
24-Sep-2020 Survey highlights physical and mental burden of anaemia of chronic kidney disease, with 41% of patients expressing feelings of social isolation Astellas Pharma Europe Ltd
24-Sep-2020 Zuhlke supported the development and launch of the new NHS Covid-19 app for England & Wales Zuhlke
24-Sep-2020 Algenex inaugurates new facility with capacity to produce up to 100 million vaccine doses Algenex SL
24-Sep-2020 Coeliac UK wins national award for its Gluten Free on the Move app - winning the category for the second year in a row Coeliac UK
24-Sep-2020 Vifor Pharma announces outcome of AFFIRM-AHF topline data Vifor Pharma
24-Sep-2020 GLEAMER raises € 7.5 million to market A.I. platform offering radiologists semi-automated diagnosis of medical images GLEAMER
24-Sep-2020 MMS and Pharmacy Automation is Easing the Pressure During COVID-19 Becton, Dickinson and Company
23-Sep-2020 Salvia BioElectronics raises EUR 26M (USD 31M) to develop innovative neurostimulation therapy for chronic migraine Salvia BioElectronics
23-Sep-2020 Aqilion announces identity of drug target and presents novel data from the drug discovery program Alnitak Aqilion
23-Sep-2020 Nemaura Medical Licenses Validated Mobile Application to Create Powerful Diabetes Prevention and Management Suite of Products Nemaura Medical, Inc.
23-Sep-2020 Janssen Presents Findings from Global, Multi-Centre Trial Examining Amivantamab in Combination with Lazertinib in Patients with EGFR-Mutated Non-Small Cell Lung Cancer The Janssen Pharmaceutical Companies of Johnson & Johnson
23-Sep-2020 Lynparza recommended for approval in EU by CHMP as 1st-line maintenance treatment with bevacizumab for HRD-positive advanced ovarian cancer AstraZeneca
23-Sep-2020 Lynparza reduced the risk of death by 31% in BRCA1/2 or ATM-mutated metastatic castration-resistant prostate cancer in PROfound Phase III trial AstraZeneca
23-Sep-2020 Switching to investigational once-weekly insulin icodec from other basal insulins demonstrated to be efficacious and well-tolerated for people with type 2 diabetes in phase 2 trial Novo Nordisk
23-Sep-2020 Preliminary Results for the year ended 30 June 2020 Allergy Therapeutics plc
23-Sep-2020 PureTech Plans U.S. Listing on Nasdaq Global Market PureTech Health
23-Sep-2020 Helsinn supports the PhD program 2020-2021 of the Institute of Oncology Research (IOR) of the Faculty of Biomedical Sciences at the Università della Svizzera italiana (USI) Helsinn
23-Sep-2020 UCB Achieves Important Regulatory Milestone for Bimekizumab UCB